Jessica A Wright
Overview
Explore the profile of Jessica A Wright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wright J, Huang L, Katamesh B, Yadav S, Singla A, Vincent A
J Cannabis Res
. 2025 Jan;
7(1):1.
PMID: 39754268
Background: Differences in cannabinoid metabolism and patient responses can arise even with equivalent doses and formulations. Genetic polymorphisms in genes responsible for cannabinoid metabolism and medications that alter CYP450 pathways...
2.
Wright J, Xu S, Wong M, El Melik R, Hodge D, Sit A
J Glaucoma
. 2024 Aug;
34(2):e9-e12.
PMID: 39133066
Purpose: Evaluate the relationship between CYP3A4 phenotype, the gene encoding the enzyme that metabolizes exogenous steroids, and the rate of steroid-induced intraocular pressure (IOP) response. Materials And Methods: Lymphocyte-derived DNA...
3.
Ferwerda M, Wright J, El Melik R, Swen J, Houwink E
Front Pharmacol
. 2024 Aug;
15:1404370.
PMID: 39108762
Background: Pharmacogenomics (PGx) is a well-established concept of how genes impact medication response, with many studies demonstrating reductions in medication side effects, improved efficacy and cost effectiveness. Despite these benefits,...
4.
Kuhn A, Determan M, Wright J, Matey E, Leung J
Ment Health Clin
. 2024 Jun;
14(3):220-223.
PMID: 38835816
Clozapine is primarily metabolized via cytochrome P450(CYP)1A2 and to a lesser extent CYP3A4, CYP2C19, and CYP2D6. Metabolic inhibitors of clozapine, such as fluvoxamine and ciprofloxacin, are important to recognize to...
5.
Varma R, Staab J, Matey E, Wright J, Deb B, Lazaridis K, et al.
Neurogastroenterol Motil
. 2023 Dec;
36(2):e14722.
PMID: 38072827
Background: How variations predicted by pharmacogenomic testing to alter drug metabolism and therapeutic response affect outcomes for patients with disorders of gut- brain interaction is unclear. Aims: To assess the...
6.
Kosaski D, Cole K, Wright J, El Melik R, Kung S, Nicholson W, et al.
Ment Health Clin
. 2023 Dec;
13(6):303-310.
PMID: 38058598
Introduction: Although there are studies assessing reasons for antidepressant discontinuation, little is known about the impact of sex differences or cytochrome P450 phenotypes. Our objective is to assess discontinuation rates...
7.
Middleton H, Boswell C, Houwink E, Allen-Rhoades W, Kuhn A, Wright J
J Prim Care Community Health
. 2023 Jun;
14:21501319231181879.
PMID: 37335086
Introduction: Acrocyanosis and erythema pernio are 2 dermatologic manifestations of vasospastic changes. Primary care providers should consider that these conditions can occur as primary or idiopathic conditions and as secondary...
8.
Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV
Zeuli J, Rivera C, Wright J, Kasten M, Mahmood M, Ragan A, et al.
AIDS
. 2023 May;
37(10):1525-1533.
PMID: 37199600
Objective: Our study aimed to assess the impact of pharmacogenomic panel testing in people with HIV (PWH). Design: Prospective, observational intervention assessment. Methods: One hundred PWH were provided a comprehensive...
9.
Huang L, Wright J, Fischer K, Croghan I, Nanda S, Schroeder D, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2023 Jan;
7(1):58-68.
PMID: 36660177
Objective: To evaluate indications for gabapentinoid prescription at an academic medical center. Patients And Methods: We retrospectively reviewed patients aged 18 years or older who were prescribed gabapentinoids (gabapentin or...
10.
Wang L, Scherer S, Bielinski S, Muzny D, Jones L, Black 3rd J, et al.
Genet Med
. 2022 Mar;
24(5):1062-1072.
PMID: 35331649
Purpose: The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a large cohort. We also generated the tools and resources necessary...